Coronavirus Update: Vaccine Developers Search For Exposed Patients, Celltrion's Infliximab Shows Promise
Despite Hotspots, Recruitment A Major Challenge
Executive Summary
As a handful of frontrunners prepare to start Phase III trials of their COVID-19 vaccine candidates, enrolling patients who are likely to be exposed to the virus is of crucial importance.